Franklin Templeton Funds - Merger of the FTF Martin Currie US Unconstrained Fund into the FTF Franklin US Opportunities Fund

Following the extraordinary general meeting (“EGM”) of shareholders in the FTF Martin Currie US Unconstrained Fund on Friday 12th September 2025 at 11:45am, we can confirm that we have received shareholder approval to merge the FTF Martin Currie US Unconstrained Fund into the FTF Franklin US Opportunities Fund. The merger will be effective as of 12.01 pm on Friday 3rd October 2025 (the “effective date”). A copy of the minutes from the EGM can be accessed here in the `Key documents' section of this page.

As a reminder to our shareholders, as the EGM has now taken place, no further votes on the merger can be accepted.

For further information please refer to the merger document pack. Other key dates relating to the merger can also be accessed here in the `Summary of the merger and key dates' section of this page. As noted in the merger document pack, we will write to all shareholders confirming the number and class of shares that they have been issued in the FTF Franklin US Opportunities Fund within 10 business days of the effective date.

We are proposing to merge the FTF Martin Currie US Unconstrained Fund (the "Current Fund") into the FTF Franklin US Opportunities Fund (the "Continuing Fund") (the "Merger"). Both the Current Fund and the Continuing Fund are sub-funds of the Franklin Templeton Funds umbrella fund range. 

We are proposing the Merger as we believe it is in the best interests of our shareholders. Currently, both the Current Fund and the Continuing Fund have the same investment objectives and can broadly make the same type of investments and both funds invest mainly in equities, i.e. in shares of companies, in the United States. Although the Continuing Fund is smaller in size than the Current Fund, we believe the Merger can provide immediate cost reduction benefits for shareholders as it charges lower fees and is less expensive to operate. We also believe that the Continuing Fund offers stronger prospects for future growth, which may lead to additional cost reductions through economies of scale over the longer term. Please note that past performance is not a guide to future performance.

In order to progress with the Merger, the Merger needs to be approved by shareholders in the Current Fund. Approval will be sought at an Extraordinary General Meeting (often abbreviated to ‘EGM’) of shareholders in the Current Fund which is being held at 11:45 AM on Friday, 12th September 2025 at Franklin Templeton’s London office: Cannon Place, 78 Cannon Street, London EC4N 6HL.

More information about the EGM, including who is eligible to vote, and how to vote, is set out in the Merger document pack which is found at the end of this webpage.

If 75% of the votes which are validly cast at the EGM are cast in favour of the Merger, it will be approved to go ahead. We consider that the proposed Merger is in the best interest of investors in the Current Fund and would urge investors to exercise their right to vote in the EGM. If you have questions about the proposed Merger, or would like to attend the EGM in person please contact our Client Service team. You can do this:

• By email to [email protected]; or
• By telephone UK freephone on 0800 305 306, or +44(0)20 7904 1843 if you are outside the UK (telephone calls may be recorded); or
• By writing to us at: Franklin Templeton, PO Box 24064, Edinburgh, EH3 1EX.

If you would like to speak to our team on the telephone, lines are open Monday to Friday from 8.30am to 5.30pm.

If you need any additional support to help you understand this letter, or any of our communications, please let the Client Service team know, and they will do their best to help you.

We will keep this webpage updated with the latest details about the proposal, including the results of the EGM – so please do check regularly to make sure you have the latest information available to you.

We believe that the proposed Merger is in the best interests of shareholders as it is expected to deliver cost reduction benefits and has the potential to deliver good outcomes for shareholders in the longer term.

We urge all investors in the Current Fund to read the Merger document pack which has been posted to you, and which is also linked to in the “Key documents” section of this webpage. A draft Key Investor Information Document (“KIID”) in respect of the W H2 Accumulation share class in the Continuing Fund has been posted to you and is available upon request. If you have any questions or would like another copy of the draft KIID please contact our Client Service team who can be reached:

• By email to [email protected]; or
• By telephone UK freephone on 0800 305 306, or +44(0)20 7904 1843 if you are outside the UK (telephone calls may be recorded); or
• By writing to us at: Franklin Templeton, PO Box 24064, Edinburgh, EH3 1EX.

If you would like to speak to our team on the telephone, lines are open Monday to Friday from 8.30am to 5.30pm.